论文部分内容阅读
目的 评价肺血管成形术在肺癌外科治疗中的临床疗效。方法 将 12 5例肺血管受累的肺癌患者 ,分为两组 :肺血管成形组 94例 ,非成形组 3 1例。比较两组间术后并发症、肺功能状态以及生存率。结果 肺血管成形组手术时间较非成形组长 ,但术后并发症两组类似 ,且成形组的术后呼吸衰竭发生率较非成形组为低 (P <0 .0 5 )。术后 1、3年生存率以及术后 1年肺通气功能 ,肺血管成形组明显优于非成形组 ,差异有显著性。结论 肺血管成形术能提高中晚期肺癌的手术切除率 ,降低全肺切除和姑息手术的比率 ,使患者的术后生存率和生活质量均得到明显改善 ,应在临床上常规应用。
Objective To evaluate the clinical effect of pulmonary angioplasty in the surgical treatment of lung cancer. Methods One hundred and twenty-five lung cancer patients with pulmonary vascular involvement were divided into two groups: 94 in the pulmonary vascular group and 31 in the unformed group. Postoperative complications, lung function status and survival rate were compared between the two groups. Results The operation time of pulmonary angioplasty group was shorter than that of non-shape group, but the postoperative complications were similar in both groups. The incidence of postoperative respiratory failure in the angioplasty group was lower than that in non-shape group (P <0.05). After 1-year and 3-year survival rates and 1 year postoperative pulmonary ventilation, the pulmonary angioplasty group was significantly better than the non-forming group, the difference was significant. Conclusions Pulmonary angioplasty can improve the surgical resection rate of lung cancer in the advanced stage and reduce the ratio of pneumonectomy and palliative surgery. The postoperative survival rate and quality of life of the patients are significantly improved, and should be routinely used clinically.